CRBK Share Price Performance

CRBK Community Fair Values

Intelligent Bio Solutions
JO
Jolt_Communications
Community Contributor
The Future of Drug Testing? Fingerprint Tech Shows Serious Promise
Key Takeaways Intelligent Bio Solutions has a new way to test for drugs using fingerprints: it’s quick, portable, and doesn’t require pee cups or saliva swabs. With commercial traction in 24 countries and over 450 active accounts, INBS is now targeting the U.S. market, where over 55 million drug tests are performed annually.
View narrative
US$2.98
FV
40.3% undervalued intrinsic discount
59.20%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
38users have followed this narrative
16 days ago author updated this narrative
Your Fair Value
CA$
Current Price
CA$0.09594.4% undervalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent CRBK News & Updates

Carebook Technologies Inc. (CVE:CRBK) Might Not Be As Mispriced As It Looks After Plunging 44%

Dec 06

Slammed 33% Carebook Technologies Inc. (CVE:CRBK) Screens Well Here But There Might Be A Catch

Oct 22

A Piece Of The Puzzle Missing From Carebook Technologies Inc.'s (CVE:CRBK) 40% Share Price Climb

Sep 07

Carebook Technologies Inc. Competitors

Canadian Market Performance

-0.3%

6.8%

18.7%

6.2%

Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. More promisingly, the market is up 19% over the past year. Earnings are forecast to grow by 12% annually. Market details ›

Carebook Technologies Stock Price

CRBK Share Price Performance

CRBK Community Fair Values

The Future of Drug Testing? Fingerprint Tech Shows Serious Promise

Recent CRBK News & Updates

Carebook Technologies' Common Shares to be Delisted from the TSX Venture Exchange at the Close of Trading on or about February 25, 2025

UIL Limited (LSE:UTL), managed by ICM Limited entered into an arrangement agreement to acquire remaining 40.6% stake in Carebook Technologies Inc. (TSXV:CRBK) from Medtech Investment, L.P and others for CAD 4.2 million.

Carebook Technologies Inc. (CVE:CRBK) Might Not Be As Mispriced As It Looks After Plunging 44%

Third quarter 2024 earnings released: CA$0.007 loss per share (vs CA$0.004 loss in 3Q 2023)

Carebook Technologies Inc. to Report Q3, 2024 Results on Nov 15, 2024

Slammed 33% Carebook Technologies Inc. (CVE:CRBK) Screens Well Here But There Might Be A Catch

A Piece Of The Puzzle Missing From Carebook Technologies Inc.'s (CVE:CRBK) 40% Share Price Climb

Carebook Technologies Inc. Competitors

ASEP Medical Holdings

Optimind Pharma

Cloud DX

Universal Ibogaine

🎢 Asia’s 2025 Rollercoaster: From Trade Turmoil to Market Rebounds

🚀 Finding Moonshots in the Space Race